glycotide semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes Semaglutide: a glucagon-like peptide-1 receptor

~ AlphaMD KPV is a small experimental peptide promoted for inflammation, digestive health, wound healing, and inflammatory skin conditions

Published in vitro research has examined GHK-Cus activity in fibroblast culture models, including its effects on collagen I and III gene expression, matrix metalloproteinase (MMP) modulation, and superoxide dismutase (SOD) activity in oxidative stress assays

In the phase 1 study, MariTide showed a weight loss of nearly 15% of initial body weight after 3 months, with results persisting for approximately 5 months after the last dose

10.1038/s41591-022-01964-3 215

But we dont need to go under the knife, or take a $1,000-a-month drug to decrap our diet

Increases in dosing are not mandatory